Drug
Alefacept
Alefacept: highest development phase Phase 2, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Alefacept NCT00301002 | Phase 2 | Psoriasis |
Latest
No recent events.
Follow Alefacept on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.